Annals of Laboratory Medicine

Korean Society for Laboratory Medicine (대한진단검사의학회)
권호 표지
DOI QR코드

DOI QR Code

A Case of Systemic Mastocytosis Associated with Acute Myeloid Leukemia Terminating as Aleukemic Mast Cell Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation

  • Bae, Mi Hyun (Department of Laboratory Medicine, University of Ulsan College of Medicine and Asan Medical Center) ;
  • Kim, Hyun-Ki (Department of Laboratory Medicine, University of Ulsan College of Medicine and Asan Medical Center) ;
  • Park, Chan-Jeoung (Department of Laboratory Medicine, University of Ulsan College of Medicine and Asan Medical Center) ;
  • Seo, Eul-Ju (Department of Laboratory Medicine, University of Ulsan College of Medicine and Asan Medical Center) ;
  • Park, Sang Hyuk (Department of Laboratory Medicine, University of Ulsan College of Medicine and Asan Medical Center) ;
  • Cho, Young-Uk (Department of Laboratory Medicine, University of Ulsan College of Medicine and Asan Medical Center) ;
  • Jang, Seongsoo (Department of Laboratory Medicine, University of Ulsan College of Medicine and Asan Medical Center) ;
  • Chi, Hyun-Sook (Department of Laboratory Medicine, University of Ulsan College of Medicine and Asan Medical Center) ;
  • Lee, Kyu-Hyung (Department of Internal Medicine, University of Ulsan College of Medicine and Asan Medical Center)
  • Published : 2013.03.02
⟨ Previous Next ⟩

Abstract

In up to 40% of systemic mastocytosis (SM) cases, an associated clonal hematological non-mast cell lineage disease such as AML is diagnosed before, simultaneously with, or after the diagnosis of SM. A 40-yr-old man was diagnosed with AML with t(8;21)(q22;q22). Mast cells were not noted at diagnosis, but appeared as immature forms at relapse. After allogeneic hematopoietic stem cell transplantation (HSCT), leukemic myeloblasts were not observed; however, neoplastic metachromatic blasts strikingly proliferated during the state of bone marrow aplasia, and finally, aleukemic mast cell leukemia developed. As the disease progressed, we observed serial morphologic changes from immature mast cells with myeloblasts to only metachromatic blasts and atypical mast cells as mast cell leukemia; FISH analysis showed that the neoplastic mast cells originated from the same clone as the leukemic myeloblasts of AML.

Keywords

References

  1. Horny HP, Metcalfe DD, Bennett JM, Bain BJ, Akin C, Escribano L, et al.. Mastocytosis. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, et al. eds. WHO classification of tumours of haematopoietic and lymphoid tissues. 4th ed. Lyon: IARC Press, 2008;54-63.
  2. Lim KH, Tefferi A, Lasho TL, Finke C, Patnaik M, Butterfield JH, et al. Systemic mastocytosis in 342 consecutive adults: survival studies and prognostic factors. Blood 2009;113:5727-36. https://doi.org/10.1182/blood-2009-02-205237
  3. Valent P, Akin C, Sperr WR, Mayerhofer M, Födinger M, Fritsche-Polanz R, et al. Mastocytosis: pathology, genetics, and current options for therapy. Leuk Lymphoma 2005;46:35-48. https://doi.org/10.1080/10428190400010775
  4. Schnittger S, Kohl TM, Haferlach T, Kern W, Hiddemann W, Spiekermann K, et al. KIT-D816 mutations in AML1-ETO-positive AML are associated with impaired event-free and overall survival. Blood 2006;107:1791-9. https://doi.org/10.1182/blood-2005-04-1466
  5. Valent P, Horny HP, Escribano L, Longley BJ, Li CY, Schwartz LB, et al. Diagnostic criteria and classification of mastocytosis: a consensus proposal. Leuk Res 2001;25:603-25. https://doi.org/10.1016/S0145-2126(01)00038-8
  6. Sperr WR, Walchshofer S, Horny HP, Födinger M, Simonitsch I, Fritsche-Polanz R, et al. Systemic mastocytosis associated with acute myeloid leukaemia: report of two cases and detection of the c-kit mutation Asp-816 to Val. Br J Haematol 1998;103:740-9. https://doi.org/10.1046/j.1365-2141.1998.01072.x
  7. Escribano L, Garca-Montero A, Núñez-Lopez R, López-Jiménez J, Almeida J, Prados A, et al. Systemic mastocytosis associated with acute myeloid leukemia: case report and implications for disease pathogenesis. J Allergy Clin Immunol 2004;114:28-33. https://doi.org/10.1016/j.jaci.2004.02.042
  8. Bernd HW, Sotlar K, Lorenzen J, Osieka R, Fabry U, Valent P, et al. Acute myeloid leukaemia with t(8;21) associated with "occult" mastocytosis. Report of an unusual case and review of the literature. J Clin Pathol 2004;57:324-8. https://doi.org/10.1136/jcp.2003.012864
  9. Pullarkat V, Bedell V, Kim Y, Bhatia R, Nakamura R, Forman S, et al. Neoplastic mast cells in systemic mastocytosis associated with t(8;21) acute myeloid leukemia are derived from the leukemic clone. Leuk Res 2007;31:261-5. https://doi.org/10.1016/j.leukres.2006.03.006
  10. Nagai S, Ichikawa M, Takahashi T, Sato H, Yokota H, Oshima K, et al. The origin of neoplastic mast cells in systemic mastocytosis with AML1/ ETO-positive acute myeloid leukemia. Exp Hematol 2007;35:1747-52. https://doi.org/10.1016/j.exphem.2007.08.016
  11. Paschka P, Marcucci G, Ruppert AS, Mrózek K, Chen H, Kittles RA, et al. Adverse prognostic significance of KIT mutations in adult acute myeloid leukemia with inv(16) and t(8;21): a Cancer and Leukemia Group B Study. J Clin Oncol 2006;24:3904-11. https://doi.org/10.1200/JCO.2006.06.9500
  12. Sperr WR, Drach J, Hauswirth AW, Ackermann J, Mitterbauer M, Mitterbauer G, et al. Myelomastocytic leukemia: evidence for the origin of mast cells from the leukemic clone and eradication by allogeneic stem cell transplantation. Clin Cancer Res 2005;11:6787-92. https://doi.org/10.1158/1078-0432.CCR-05-1064
  13. Chen TY, Chen JS, Huang WT, Su WC, Tsao CJ. Rapid engraftment of mast cells of donor origin in a case of acute myeloid leukemia with mast cell leukemia after allogeneic stem cell transplantation. Bone Marrow Transplant 2003;32:111-4. https://doi.org/10.1038/sj.bmt.1704098
  14. Parker RI. Hematologic aspects of systemic mastocytosis. Hematol Oncol Clin North Am 2000;14:557-68. https://doi.org/10.1016/S0889-8588(05)70296-3
  15. Spyridonidis A, Thomas AK, Bertz H, Zeiser R, Schmitt-Graff A, Lindemann A, et al. Evidence for a graft-versus-mast-cell effect after allogeneic bone marrow transplantation. Bone Marrow Transplant 2004;34:515-9. https://doi.org/10.1038/sj.bmt.1704627

Cited by

  1. Refined diagnostic criteria and classification of mast cell leukemia (MCL) and myelomastocytic leukemia (MML): a consensus proposal vol.25, pp.9, 2014, https://doi.org/10.1093/annonc/mdu047
  2. (Lymph)angiogenic influences on hematopoietic cells in acute myeloid leukemia vol.46, pp.11, 2014, https://doi.org/10.1038/emm.2014.72
  3. De novo Leukemic Variant of Mast Cell Leukemia With KIT D816V vol.35, pp.2, 2013, https://doi.org/10.3343/alm.2015.35.2.260
  4. Pharmacological treatment options for mast cell activation disease vol.389, pp.None, 2016, https://doi.org/10.1007/s00210-016-1247-1
  5. Shared clonal cytogenetic abnormalities in aberrant mast cells and leukemic myeloid blasts detected by single nucleotide polymorphism microarray‐based whole‐genome scanning vol.55, pp.4, 2013, https://doi.org/10.1002/gcc.22342
  6. Acute Myeloid Leukemia With Inv(16)(p13q22) Associated With Hidden Systemic Mastocytosis: Case Report and Review of Literature vol.10, pp.None, 2013, https://doi.org/10.1177/1179545x17700858
  7. The roles of mast cells in allergic inflammation and mast cell-related disorders vol.5, pp.5, 2013, https://doi.org/10.4168/aard.2017.5.5.248
  8. KIT D816V Positive Acute Mast Cell Leukemia Associated with Normal Karyotype Acute Myeloid Leukemia vol.2018, pp.None, 2013, https://doi.org/10.1155/2018/3890361
  9. A case report of systemic mastocytosis associated with multiple hematologic non–mast cell lineage diseases vol.37, pp.2, 2019, https://doi.org/10.1002/hon.2605